Cardiovascular comorbidities |
Cardiovascular comorbidities |
Cardiovascular comorbidities |
Cardiovascular comorbidities |
Cardiovascular comorbidities |
Cardiovascular comorbidities |
Cardiovascular comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
9874
|
67453.32
|
3044
|
4512.75
|
1.00
|
1.00
|
Male
|
5223
|
35926.71
|
1766
|
4915.56
|
1.09 (1.03~1.16)
|
1.10 (1.04~1.17)
|
Age
|
|
|
|
|
|
|
≤ 16
|
356
|
3055.91
|
5
|
163.62
|
1.00
|
1.00
|
>16
|
14741
|
100324.12
|
4805
|
4789.48
|
28.63 (11.91~68.01)
|
29.11 (12.11~69.98)
|
Biologic agents
|
|
|
|
|
|
|
No
|
14976
|
102282.55
|
4801
|
4693.86
|
1.00
|
1.00
|
Yes
|
121
|
1097.49
|
9
|
820.05
|
0.18 (0.09~0.35)
|
0.18 (0.09~0.35)
|
Metabolic comorbidities |
Metabolic comorbidities |
Metabolic
comorbidities |
Metabolic comorbidities |
Metabolic comorbidities |
Metabolic comorbidities |
Metabolic comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
8405
|
53287.36
|
3663
|
43581.20
|
1.00
|
1.00
|
Male
|
4979
|
33172.56
|
2017
|
40510.14
|
0.89 (0.85~0.94)
|
0.90 (0.85~0.95)
|
Age
|
|
|
|
|
|
|
≤ 16
|
350
|
2906.98
|
28
|
8000.00
|
1.00
|
1.00
|
>16
|
13034
|
83552.95
|
5652
|
43363.51
|
6.79 (4.69~9.84)
|
6.72 (4.64~9.75)
|
Biologic agents
|
|
|
|
|
|
|
No
|
13295
|
85638.11
|
5671
|
42655.13
|
1.00
|
1.00
|
Yes
|
89
|
821.82
|
9
|
10112.36
|
0.17 (0.09~0.33)
|
0.17 (0.09~0.32)
|
Rheumatology comorbidities |
Rheumatology comorbidities |
Rheumatology
comorbidities |
Rheumatology comorbidities |
Rheumatology comorbidities |
Rheumatology comorbidities |
Rheumatology comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
11742
|
91810.66
|
1472
|
12536.19
|
1.00
|
1.00
|
Male
|
6372
|
51469.19
|
797
|
12507.85
|
0.97 (0.89~1.06)
|
0.97 (0.89~1.06)
|
Age
|
|
|
|
|
|
|
≤ 16
|
339
|
2838.61
|
20
|
5899.71
|
1.00
|
1.00
|
>16
|
17775
|
140441.23
|
2249
|
12652.60
|
2.25 (1.45~3.50)
|
2.25 (1.45~3.49)
|
Biologic agents
|
|
|
|
|
|
|
No
|
17976
|
142017.51
|
2262
|
12583.44
|
1.00
|
1.00
|
Yes
|
138
|
1262.33
|
7
|
5072.46
|
0.36 (0.17~0.75)
|
0.35 (0.17~0.74)
|
Oncology comorbidities |
Oncology comorbidities |
Oncology comorbidities |
Oncology comorbidities |
Oncology comorbidities |
Oncology
comorbidities |
Oncology comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
1974
|
106819.39
|
12720
|
644376.90
|
1.00
|
1.00
|
Male
|
1174
|
60389.63
|
6961
|
592930.15
|
1.04 (0.97~1.12)
|
1.04 (0.97~1.12)
|
Age
|
|
|
|
|
|
|
≤ 16
|
10
|
3121.68
|
358
|
3580000.00
|
1.00
|
1.00
|
>16
|
3138
|
164087.34
|
19323
|
615774.38
|
6.23 (3.35~11.58)
|
6.26 (3.37~11.64)
|
Biologic agents
|
|
|
|
|
|
|
No
|
3125
|
165753.94
|
19525
|
624800.00
|
1.00
|
1.00
|
Yes
|
23
|
1455.08
|
156
|
678260.87
|
0.65 (0.43~0.98)
|
0.65 (0.43~0.98)
|
Infection comorbidities |
Infection comorbidities |
Infection
comorbidities |
Infection comorbidities |
Infection comorbidities |
Infection comorbidities |
Infection comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
12278
|
100003.67
|
646
|
5261.44
|
1.00
|
1.00
|
Male
|
6666
|
55516.31
|
446
|
6690.67
|
1.25 (1.11~1.41)
|
1.26 (1.11~1.42)
|
Age
|
|
|
|
|
|
|
≤ 16
|
357
|
3095.73
|
5
|
1400.56
|
1.00
|
1.00
|
>16
|
18587
|
152424.25
|
1087
|
5848.17
|
4.37 (1.81~10.51)
|
4.50 (1.87~10.83)
|
Biologic agents
|
|
|
|
|
|
|
No
|
18797
|
154185.62
|
1085
|
5772.20
|
1.00
|
1.00
|
Yes
|
147
|
1334.37
|
7
|
4761.90
|
0.77 (0.36~1.61)
|
0.81 (0.38~1.70)
|
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Miscellaneous comorbidities |
Gender
|
|
|
|
|
|
|
Female
|
8545
|
53604.52
|
3206
|
5980.84
|
1.00
|
1.00
|
Male
|
4502
|
28281.48
|
1790
|
6329.23
|
1.06 (1.01~1.13)
|
1.07 (1.01~1.13)
|
Age
|
|
|
|
|
|
|
≤ 16
|
273
|
2094.36
|
49
|
2339.62
|
1.00
|
1.00
|
>16
|
12774
|
79791.65
|
4947
|
6199.90
|
2.52 (1.90~3.34)
|
2.55 (1.92~3.38)
|
Biologic agents
|
|
|
|
|
|
|
No
|
8601
|
53954.71
|
3220
|
5967.97
|
1.00
|
1.00
|
Yes
|
93
|
826.53
|
7
|
846.92
|
0.15 (0.07~0.31)
|
0.15 (0.07~0.31)
|